Unichem Labs gets USFDA nod for asthma drug

The tablets are indicated for prophylaxis and chronic treatment of asthma in adults and pediatric patients - 12 months of age and older.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news